Despite a recent share price increase, the company's low P/S...
Despite a recent share price increase, the company's low P/S ratio, likely due to declining revenue and poor industry performance, may continue to limit the share price unless medium-term conditions improve.
Hubei Guangji Pharmaceutical Co., Ltd. (SZSE:000952) Surges 25% Yet Its Low P/S Is No Reason For Excitement
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment